host
antivir
gene
import
regul
antivir
immun
plausibl
genet
determin
immun
respons
heterogen
vaccin
genotyp
analyz
common
candid
tagsnp
antivir
gene
cohort
schoolchildren
immun
two
dose
measlesmumpsrubella
mmr
vaccin
associ
snpshaplotyp
measl
virusspecif
immun
outcom
assess
use
linear
regress
methodolog
caucasian
africanamerican
genet
variant
within
gene
includ
code
polymorph
associ
singlesnp
p
although
snp
remain
signific
correct
fals
discoveri
ratefdr
haplotypelevel
analysi
measlesspecif
antibodi
variat
caucasian
haplotyp
allel
pvalu
haplotyp
global
pvalu
four
polymorph
high
ld
demonstr
also
associ
correct
fdr
variat
measlesspecif
secret
caucasian
p
q
two
intron
polymorph
includ
function
snp
p
demonstr
evid
associ
signific
alleledoserel
increas
neutral
antibodi
level
africanamerican
genotyp
haplotypelevel
associ
demonstr
role
adar
genet
variant
includ
nonsynonym
snp
p
regul
measl
virusspecif
elispot
respons
caucasian
haplotyp
global
pvalu
correct
fdr
singlesnp
associ
snp
caucasian
snp
africanamerican
still
remain
signific
qvalu
conclus
find
strongli
point
genet
variantsgen
involv
antivir
sens
antivir
control
critic
determin
differenti
modul
adapt
immun
respons
live
attenu
measl
vaccin
caucasian
africanamerican
attenu
measl
vaccin
offer
opportun
consider
reduc
measlesrel
morbid
mortal
howev
measl
still
public
health
issu
approxim
death
worldwid
rel
increas
report
case
sever
european
countri
unit
state
includ
case
individu
two
dose
mmr
vaccin
therefor
establish
effect
measl
immun
across
popul
crucial
requir
provid
immun
coverag
surveil
detect
new
case
outbreak
despit
measl
control
erad
question
still
remain
regard
document
primari
failur
rate
vaccin
immunogenet
caus
vaccin
respons
heterogen
andor
vaccin
failur
deeper
understand
observ
interindividu
differ
immun
respons
measl
vaccin
need
provid
new
insight
improv
vaccineinduc
humor
cellular
innat
immun
respons
design
better
vaccin
first
line
defens
innat
immun
orchestr
host
respons
prevent
reduc
viral
replic
spread
adapt
immun
system
switch
elimin
specif
invad
pathogen
cellular
viral
sensor
type
iii
interferon
ifn
ifn
ifn
ifn
ifntrigg
antivir
protein
long
recogn
crucial
mediat
innat
antivir
defens
import
effect
magnitud
qualiti
innat
adapt
immun
respons
import
antivir
factor
pathway
retino
acidinduc
gene
protein
melanoma
differenti
associ
mitochondri
antivir
signal
protein
dsrnaactiv
protein
kinas
r
oligoadenylatesynthetas
oa
ribonucleas
l
rnasel
pathway
mx
protein
gtpase
adenosin
deaminas
rnaspecif
adar
ubiquitinlik
pathway
other
play
role
viral
sens
control
pathogenesi
outcom
viral
infect
polymorph
ifnstimul
antivir
effector
gene
cellular
viral
sensor
potenti
genet
determin
immun
respons
heterogen
may
influenc
immun
respons
viral
vaccin
alter
function
antivir
effect
correspond
protein
genet
variant
gene
implic
import
regul
immun
host
respons
infect
bear
mind
multifacet
interact
virus
factor
innat
immun
system
studi
sought
investig
first
time
role
key
antivir
effector
protein
cellular
antivir
sensor
plausibl
contributor
immun
respons
heterogen
live
attenu
measl
vaccin
reason
perform
comprehens
candid
gene
associ
studi
larg
racial
divers
cohort
healthi
schoolchildren
two
dose
mmr
vaccin
result
suggest
multipl
innat
immun
genet
variantsgen
like
involv
modul
adapt
immun
respons
live
attenu
measl
vaccin
caucasian
africanamerican
studi
cohort
consist
independ
agestratifi
sampl
randomli
recruit
healthi
schoolchildren
young
adult
olmst
counti
minnesota
describ
previous
briefli
cohort
enrol
compris
sampl
subject
age
year
elig
current
studi
cohort
enrol
cohort
enrol
year
consist
elig
subject
age
year
studi
particip
resid
commun
case
measl
infect
report
lifetim
receiv
two
dose
mmrii
vaccin
merck
whitehous
station
nj
contain
edmonston
strain
measl
viru
tcid
mayo
clinic
institut
review
board
grant
approv
studi
written
inform
consent
obtain
parentsguardian
well
written
assent
ageappropri
subject
time
enrol
studi
demograph
clinic
variabl
studi
cohort
describ
previous
briefli
studi
cohort
n
subject
use
genet
associ
studi
consist
male
femal
two
preval
racial
group
use
caucasian
africanamerican
studi
subject
nonhispan
median
age
enrol
year
interquartil
rangeiqr
median
age
first
second
immun
month
iqr
year
iqr
respect
median
time
second
immun
enrol
immun
measur
year
iqr
measur
neutral
antibodi
measl
viru
use
high
throughput
fluorescencebas
prmn
previous
describ
follow
modif
readout
use
autom
olympu
fluoresc
microscop
system
imagepro
plu
softwar
version
mediacybernet
scan
count
gfpposit
plaqu
calcul
end
point
titer
neutral
dose
nd
perform
use
karber
formula
nd
valu
transform
miuml
valu
use
intern
antimeasl
antibodi
standard
nibsc
code
previous
describ
human
total
elispot
kit
r
system
minneapoli
mn
use
measur
number
cell
previous
describ
follow
manufactur
protocol
briefli
stimul
subject
peripher
blood
mononuclear
cellspbmc
altern
left
unstimul
triplic
edmonston
strain
measl
viru
multipl
infect
moi
develop
reaction
h
incub
c
co
phytohaemagglutininpha
gml
use
posit
control
plate
scan
analyz
use
count
paramet
immunospot
pro
analyz
cellular
technolog
ltd
cleveland
oh
usa
use
immunospot
version
softwar
cellular
technolog
ltd
secret
cytokin
innateinflammatori
quantifi
pbmc
cultur
vitro
stimul
live
measl
viru
stimul
unstimul
five
replic
measur
use
preoptim
condit
moi
incub
time
cytokin
previous
describ
differ
cytokin
measur
use
follow
condit
moi
h
moi
h
moi
h
secret
cytokin
level
measur
commerci
kit
accord
manufactur
recommend
r
system
minneapoli
mn
mabtech
cincinnati
oh
bd
bioscienc
pharmingen
san
diego
ca
rest
cytokin
snp
select
approach
genotyp
methodolog
publish
previou
genet
associ
studi
briefli
use
tagsnp
select
approach
base
linkag
disequilibrium
ld
select
snp
antivir
gene
includ
region
kb
upstream
downstream
gene
sourc
greatest
number
snp
among
hapmap
phase
ii
http
wwwhapmaporg
seattl
snp
http
pgambtwashingtonedu
nieh
snp
http
egpgswashingtonedu
bin
snp
minor
allel
frequenc
maf
pairwis
ld
threshold
r
success
illumina
predict
genotyp
score
caucasian
sampl
africanamerican
sampl
separ
use
ldselect
program
accommod
set
illumina
platform
constraint
snp
list
postprocess
refin
use
snppicker
program
also
ad
set
function
oblig
snp
code
nonsynonym
synonym
untransl
region
final
list
total
snp
across
antivir
gene
select
base
approach
nomenclatur
use
descript
polymorph
follow
describ
den
dunnen
antonaraki
genotyp
select
snp
use
two
custom
illumina
goldeng
snp
panel
illumina
inc
san
diego
ca
snp
use
genotyp
candid
snp
larg
populationbas
measl
vaccin
studi
dna
sampl
n
genotyp
follow
manufactur
protocol
previous
describ
seven
hundr
sixti
four
n
subject
initi
genotyp
known
snp
antivir
gene
document
role
antivir
immun
mavsvisa
rnasel
adar
genotyp
locu
success
rate
sampl
success
rate
includ
replic
sampl
reproduc
due
insufficientinadequt
dna
qualiti
genotyp
failur
low
call
rate
nineteen
dna
sampl
fail
leav
subject
analysi
snp
includ
genotyp
eighteen
snp
fail
initi
qualiti
control
failur
amplifi
poor
cluster
multipl
replic
error
snp
yield
genotyp
data
addit
snp
also
exclud
analysi
base
low
maf
n
base
monomorph
n
total
snp
use
final
racespecif
analysi
caucasian
africanamerican
statist
method
describ
herein
similar
publish
previou
genet
associ
studi
data
descript
summar
use
frequenc
percentag
categor
variabl
median
interquartil
rang
continu
variabl
assess
cytokin
secret
cellmedi
immun
cmi
measur
result
multipl
record
valu
per
outcom
prior
stimul
measl
viru
descript
purpos
singl
respons
measur
per
individu
obtain
outcom
subtract
median
unstimul
valu
median
stimul
valu
assess
antibodi
level
result
one
record
valu
per
individu
observ
genotyp
use
estim
allel
frequenc
snp
departur
hardyweinberg
equilibrium
hwe
assess
use
either
pearson
goodnessoffit
test
snp
minor
allel
frequenc
maf
less
fisher
exact
test
estim
pairwis
linkag
disequilibrium
ld
base
rsquar
statist
obtain
use
haploview
softwar
version
snp
associ
immun
respons
outcom
evalu
use
regress
model
simpl
linear
regress
use
measl
antibodi
level
one
measur
valu
per
individu
repeat
measur
approach
implement
cytokin
secret
elispot
variabl
simultan
model
multipl
observ
measur
use
unstructur
withinperson
variancecovari
matrix
account
withinsubject
correl
achiev
includ
genotyp
variabl
regress
model
togeth
variabl
repres
stimul
statu
result
genotypebystimul
statu
interact
test
statist
signific
test
associ
assum
ordin
logaddit
snp
effect
use
simpl
test
trend
lack
seroneg
subject
prmn
titer
cohort
low
number
subject
antibodi
concentr
less
protect
threshold
miuml
correspond
prmn
titer
statist
approach
rational
assess
associ
snp
quantit
humoralcellular
immun
outcom
across
entir
cohort
use
linear
regress
methodolog
rather
assess
distribut
snp
across
extrem
humoralcellular
immun
respons
seroneg
subject
andor
subject
antibodi
concentr
less
protect
titer
explor
genom
region
contain
statist
signific
singlesnp
effect
perform
post
hoc
haplotyp
analys
posterior
probabl
possibl
haplotyp
individu
condit
observ
genotyp
estim
use
expectationmaxim
em
algorithm
inform
use
defin
haplotyp
design
variabl
estim
number
haplotyp
carri
individu
analys
perform
result
common
haplotyp
estim
frequenc
use
simpl
least
squar
linear
regress
approach
antibodi
level
repeat
measur
approach
cmi
variabl
differ
immun
respons
among
common
haplotyp
first
assess
global
simultan
test
statist
signific
use
multipl
degreeoffreedom
test
follow
global
test
examin
individu
haplotyp
effect
haplotyp
includ
separ
regress
analysi
effect
compar
immun
respons
level
haplotyp
interest
other
combin
due
phase
ambigu
haplotypespecif
median
interquartil
rang
could
calcul
thu
descript
summari
repres
use
correspond
tstatist
associ
analys
describ
separ
perform
within
two
preval
racial
group
caucasian
africanamerican
analysi
also
adjust
gender
age
first
measl
vaccin
age
second
measl
vaccin
age
enrol
thu
account
time
sinc
last
vaccin
enrollmentblood
draw
immun
measur
cohort
statu
cohort
vs
cohort
use
invers
normal
transform
cytokin
secret
elispot
outcom
variabl
log
transform
antibodi
respons
measur
formal
test
account
skew
natur
data
larg
number
statist
test
comput
qvalu
snp
estim
correspond
fals
discoveri
rate
fdr
per
storey
tibshirani
consid
snp
signific
qvalu
less
howev
also
report
singlesnp
associ
interest
followup
qvalu
less
correspond
singlesnp
pvalu
roughli
statist
test
twosid
unless
otherwis
indic
analys
carri
use
sa
softwar
system
sa
institut
inc
cari
nc
immun
characterist
studi
cohort
summar
tabl
median
level
measlesspecif
neutral
antibodi
humor
immun
studi
cohort
miuml
interquartil
rangeiqr
median
elispot
respons
cellular
immun
spot
per
cell
iqr
median
measlesspecif
secret
level
cohort
pgml
iqr
median
measlesspecif
secret
level
pgml
iqr
median
measlesspecif
secret
level
pgml
iqr
racespecif
analysi
caucasian
group
identifi
two
signific
associ
snp
locat
antivir
gene
neutral
antibodi
level
measl
vaccin
p
well
one
suggest
snp
associ
p
tabl
intron
snp
rigi
gene
associ
allel
doserel
increas
calcul
ratio
minu
one
immun
outcom
observ
homozyg
minor
allel
genotyp
immun
outcom
observ
homozyg
major
allel
genotyp
multipli
humor
respons
defin
measlesspecif
miuml
titer
prmn
assay
cytokin
respons
defin
subjectspecif
median
measlesstimul
respons
measur
five
replic
minu
median
unstimul
respons
also
measur
five
replic
elispot
respons
defin
subjectspecif
median
measlesstimul
respons
measur
triplic
minu
median
unstimul
respons
also
measur
triplic
valu
report
miuml
antibodi
respons
pgml
secret
cytokin
cytokineposit
spot
per
cell
elispot
respons
iqr
interquartil
rang
b
antibodi
respons
subject
report
posit
posit
protect
titer
higher
protect
threshold
miuml
correspond
subject
consid
posit
cytokin
respons
median
stimul
cell
larger
median
unstimul
cell
antibodi
level
p
intron
snp
found
ld
r
synonym
snp
also
demonstr
allel
dose
relationship
higher
neutral
antibodi
level
approxim
increas
antibodi
although
associ
reach
statist
signific
p
p
tabl
addit
eight
snp
display
suggest
associ
antibodi
level
racial
group
p
data
shown
intron
genet
variant
within
visa
gene
demonstr
associ
antibodi
level
caucasian
group
p
analysi
restrict
africanamerican
subject
reveal
three
signific
intron
snp
associ
measlesspecif
humor
immun
respons
p
tabl
importantli
analysi
identifi
associ
function
genet
variant
locat
intron
spliceacceptor
site
minor
allel
two
intron
snp
associ
signific
increas
increas
increas
measl
neutral
antibodi
allel
doserel
manner
p
tabl
howev
adjust
fals
discoveri
rate
fdr
none
identifi
snp
list
tabl
remain
signific
qvalu
although
report
snp
associ
demonstr
qvalu
two
snp
associ
demonstr
qvalu
racespecif
analysi
caucasian
group
reveal
six
signific
associ
genet
variant
two
antivir
gene
adar
measlesspecif
elispot
respons
p
tabl
four
adar
snp
high
ld
r
includ
nonsynonym
adar
snp
demonstr
allel
doserel
increas
elispot
respons
racial
group
represent
minor
allel
p
tabl
furthermor
observ
three
addit
adar
snp
demonstr
suggest
associ
immun
outcom
caucasian
group
p
data
shown
analysi
africanamerican
group
reveal
five
associ
snp
belong
five
antivir
gene
measlesspecif
cellular
immun
p
tabl
synonym
polymorph
found
associ
elispot
respons
racial
group
p
tabl
minor
allel
two
intron
snp
snp
p
snp
p
demonstr
signific
allel
doserel
variat
decreas
increas
respect
immun
outcom
tabl
adjust
fals
discoveri
rate
fdr
none
identifi
snp
tabl
remain
signific
qvalu
although
report
snp
associ
demonstr
qvalu
one
snp
associ
demonstr
qvalu
explor
genom
region
enrich
statist
signific
p
suggest
p
data
shown
singlesnp
associ
perform
haplotyp
analys
adar
gene
region
haplotyp
level
analysi
reveal
genet
variantshaplotyp
within
adar
gene
haploview
output
present
fig
associ
measlesspecif
humor
cellular
immun
elispot
respect
caucasian
africanamerican
haplotyp
allel
pvalu
adar
global
pvalu
tabl
particularli
haplotyp
ggaaaaaaaa
associ
decreas
antibodi
level
haplotyp
tstatist
allel
pvalu
compar
haplotyp
adar
haplotyp
ataatcgggaaaggaa
associ
increas
elispot
respons
haplotyp
tstatist
allel
pvalu
caucasian
group
tabl
found
signific
associ
p
caucasian
africanamerican
group
respect
genet
variant
antivir
effector
gene
measlesspecif
secret
innateinflammatori
cytokin
howev
snp
associ
cytokin
secret
immun
outcom
meet
fdr
threshold
analysi
caucasian
group
reveal
seven
signific
snp
associ
measlesspecif
secret
remain
signific
qvalu
adjust
fdr
p
q
tabl
two
intron
snp
demonstr
alleledos
relationship
lower
secret
level
p
addit
minor
allel
four
snp
high
ld
r
associ
signific
allel
doserel
decreas
approxim
secret
caucasian
group
tabl
interestingli
four
snp
demonstr
reduct
measlesspecif
secret
level
represent
minor
allel
caucasian
group
still
remain
signific
adjust
fdr
p
q
tabl
note
three
snp
r
also
found
associ
haplotyp
level
variat
measlesspecif
humor
immun
caucasian
tabl
analysi
africanamerican
group
reveal
four
signific
snp
associ
measlesspecif
secret
remain
signific
qvalu
adjust
fdr
p
q
supplementari
tabl
particular
minor
allel
two
snp
intergen
region
bold
snp
associ
allel
doserel
decreas
secret
level
polymorph
p
q
present
tabl
valu
present
homozyg
major
alleleheterozygoushomozyg
minor
allel
n
indic
number
subject
specif
genotyp
indic
genotyp
count
percentag
b
iqr
interquartil
rang
valu
median
level
cytokin
pgml
measur
elisa
c
ordin
pvalu
repeat
measur
linear
regress
analysi
adjust
age
enrol
gender
age
first
second
mmr
immun
cohort
statu
cohort
cohort
correspond
qvalu
adjust
fdr
fig
haplotyp
block
structur
adar
genet
variant
studi
cohort
caucasian
sampl
schemat
gene
represent
ld
block
structur
b
adar
genet
variant
depict
ld
block
structur
analyz
use
haploview
softwar
version
snp
present
b
directli
genotyp
studi
r
color
scheme
white
r
shade
grey
r
black
r
number
report
r
valu
multipli
gene
high
ld
associ
signific
increas
secret
allel
doserel
manner
p
q
supplementari
tabl
summar
identifi
two
four
adar
genet
variant
well
adar
haplotyp
associ
neutral
antibodi
level
measlesspecif
cellular
immun
elispot
respect
caucasian
group
four
polymorph
associ
neutral
antibodi
variat
haplotyp
level
demonstr
signific
associ
variat
secret
caucasian
two
genet
variant
includ
function
snp
associ
humor
immun
respons
variat
africanamerican
group
variou
genet
variant
gene
implic
import
regul
immun
viral
vaccin
includ
measl
vaccin
cytokin
cytokin
receptor
tolllik
receptor
tlr
signal
molecul
viral
receptor
slam
dcsign
measl
viru
vitamin
receptor
object
populationbas
studi
comprehens
evalu
influenc
human
genet
variat
key
host
antivir
sensor
antivir
effector
gene
immun
respons
heterogen
measl
vaccin
genet
polymorph
snp
gene
relat
innat
immun
interferon
gene
type
ifn
receptor
gene
antiretrovir
gene
tlr
known
associ
variat
immun
respons
measl
rubella
vaccin
previous
demonstr
specif
variat
antivir
sensor
gene
mavsvisa
key
ifninduc
antivir
gene
particularli
polymorph
oa
gene
cluster
associ
differ
rubella
vaccineinduc
adapt
immun
littl
known
regard
import
gene
variat
measlesspecif
immun
furthermor
multipl
previou
genet
associ
studi
reveal
polymorph
oasl
pkr
gene
correl
respons
ifn
therapi
andor
suscept
virus
wnv
hcv
hbv
sarscov
measl
viru
genet
data
singl
snp
haplotyp
analys
point
possibl
involv
genet
variant
within
rigi
gene
includ
code
polymorph
antibodi
variat
follow
measl
vaccin
caucasian
haplotyp
allel
pvalu
mitochondri
antivir
pathway
involv
detect
viral
rna
cytosol
helicas
belong
rigilik
helicas
famili
downstream
signal
interact
visamavscardif
adaptor
protein
addit
vitamin
metabolit
known
affect
measl
replic
antibodi
respons
vitamin
supplement
link
ifn
type
idepend
mechan
genet
variant
within
antivir
sensor
gene
associ
differ
measlesspecif
immun
outcom
studi
includ
common
genet
variant
regul
antibodi
respons
measlesspecif
secret
caucasian
group
consist
recent
report
recognit
measl
viru
rigi
instig
interferonspecif
innat
immun
respons
interestingli
common
code
function
polymorph
known
modul
transcript
dendrit
cell
suggest
plausibl
regul
rubella
vaccineinduc
humor
immun
associ
measlesspecif
secret
africanamerican
sampl
although
remain
signific
adjust
fdr
p
q
data
shown
addit
analysi
genet
associ
measlesspecif
vaccin
respons
reveal
enrich
represent
genet
variant
within
oa
cluster
gene
tabl
supplementari
tabl
interferoninduc
protein
known
catalyz
synthesi
oligoadenyl
activ
rnase
l
result
antivir
viral
rna
degrad
inhibit
viral
replic
proapoptot
activ
genet
polymorph
code
gene
link
variou
immunolog
infecti
outcom
involv
oa
genet
variant
regul
measl
vaccineimmun
respons
highli
plausibl
bear
mind
oa
genet
variat
like
involv
modul
adapt
immun
respons
live
attenu
rubella
vaccin
particularli
convinc
associ
snp
polymorph
establish
function
variat
measlesspecif
humor
immun
respons
increas
associ
homozyg
minor
allel
genotyp
africanamerican
sampl
p
genet
variant
locat
intron
spliceacceptor
site
demonstr
regul
splice
result
isoform
differ
enzym
activ
recent
data
literatur
suggest
genet
variat
alter
viral
replic
human
lymphoid
tissu
risk
factor
infect
west
nile
viru
addit
previou
work
link
polymorph
addit
oa
polymorph
variat
rubella
vaccineinduc
cytokin
secret
anoth
interest
antivir
gene
potenti
associ
measl
virusspecif
immun
variat
adar
involv
rna
edit
substitut
adenosin
inosin
cellular
mrna
viral
dsrna
target
data
show
evid
associ
nonsynonym
snp
ld
signific
adar
snp
r
measl
virusspecif
cellular
immun
elispot
respons
caucasian
p
tabl
consist
current
find
previou
rubella
vaccin
studi
demonstr
increas
rubellaspecif
respons
p
represent
minor
allel
genotyp
adar
polymorph
suggest
involv
genegenet
variant
immun
respons
variat
vaccin
addit
regulatori
intron
snp
within
gene
associ
genotyp
haplotyp
level
variat
measlesspecif
cellular
immun
particularli
caucasian
group
haplotyp
global
pvalu
tabl
impli
cooper
effect
multipl
snp
genet
regul
immun
outcom
concert
identif
adar
critic
determin
local
system
inflammatori
respons
rna
edit
modul
protein
product
import
howev
note
find
similar
genesgenet
variant
associ
measlesspecif
elispot
respons
cytokin
secret
analys
caucasian
genet
associ
secret
remain
signific
adjust
fdr
none
snp
associ
elispot
respons
remain
signific
adjust
assay
quantifi
respons
report
previous
assay
correl
well
elispot
measur
number
cytokineproduc
cell
elisa
measur
cytokin
protein
concentr
releas
cultur
supernat
virusstimul
cell
specul
lack
correl
weak
correl
two
assay
like
main
reason
differ
genet
associ
found
analys
two
immun
outcom
find
point
plausibl
role
sever
interrog
innat
immun
gene
observ
interindividu
variat
follow
measl
vaccin
although
observ
interpret
caution
sinc
mani
singlesnp
associ
remain
signific
adjust
fdr
q
identifi
gene
influenc
vaccineinduc
measl
immun
interconnect
compon
innat
antivir
respons
target
viral
nucleic
acid
viral
nucleic
acid
stimul
oasrnas
l
pathway
result
rna
degrad
viral
rna
also
target
adar
deamin
viral
replic
intermedi
addit
viral
rna
activ
rna
helicaselik
receptor
includ
rigi
initi
signal
transcript
ifn
irf
feed
back
receptor
increas
express
antivir
protein
thu
augment
antivir
respons
henc
find
impli
key
genet
variantsgen
involv
initi
antivir
respons
viral
nucleic
acid
modul
immun
respons
vaccin
live
viral
vaccin
like
due
alter
viral
sens
andor
direct
antivir
activ
restrict
viral
replic
antigen
loadantigen
stimul
although
gene
adar
even
genet
variant
found
associ
variat
rubella
vaccin
measl
vaccineinduc
immun
respons
studi
identifi
genet
variant
associ
pattern
appear
virusspecif
possibl
due
differ
virus
respect
abil
induc
andor
counter
involv
protein
antivir
pathway
major
strength
studi
use
rel
larg
racial
divers
cohort
healthi
vaccin
two
dose
mmr
vaccin
extens
demograph
clinic
inform
avail
known
contact
wild
type
measl
viru
infect
allow
us
probe
racespecif
associ
two
preval
racial
group
caucasian
africanamerican
vaccineinduc
immun
outcom
studi
cohort
novel
aspect
present
studi
comprehens
list
genet
variant
genotyp
across
key
antivir
gene
never
studi
context
measl
vaccin
respons
heterogen
correl
clinic
relev
vaccineinduc
immun
outcom
neutral
antibodi
level
recogn
real
possibl
report
associ
reflect
falseposit
result
particularli
smaller
sampl
size
reduc
power
avail
racespecif
analysi
work
choos
report
find
two
preval
racial
group
caucasian
africanamerican
separ
allel
frequenc
vari
consider
racial
ethnic
group
thu
confound
result
importantli
genessnp
genet
associ
pattern
identifi
studi
differ
caucasian
africanamerican
racial
group
studi
surpris
given
differ
allel
frequenc
immun
respons
gene
report
two
race
well
differ
allelehaplotyp
frequenc
observ
two
group
studi
plausibl
differ
genet
polymorph
would
import
popul
african
children
find
cohort
older
children
minnesota
area
high
vaccin
coverag
may
appli
area
world
low
vaccin
coverag
mainli
younger
children
differ
raceethn
contract
diseas
also
acknowledg
rel
larg
number
comparison
analys
address
multipl
test
issu
adjust
fdr
supplement
pvalu
correspond
qvalu
correct
fdr
snp
report
singlesnp
associ
level
p
snp
caucasian
snp
africanamerican
still
remain
signific
qvalu
first
studi
assess
polymorph
antivir
gene
possibl
effect
measl
vaccineinduc
immun
racespecif
manner
chose
also
use
less
stringent
qvalu
cutoff
valu
roughli
correspond
pvalu
singlesnp
associ
believ
risk
fals
neg
outweigh
fals
posit
nevertheless
high
biolog
plausibl
genet
variant
haplotypelevel
associ
observ
allel
doserel
relationship
crossregul
differ
immun
outcom
genet
variant
consider
effect
immun
outcom
measur
increas
confid
report
find
followup
replic
functionbas
studi
plan
valid
extend
result
increas
understand
mechan
involv
immun
respons
variat
measl
vaccin
potenti
inform
develop
new
andor
improv
vaccin
support
novel
paradigm
vaccin
develop
concept
call
vaccinom
taken
togeth
increas
evid
role
novel
innat
immun
gene
oa
adar
regul
measl
vaccin
adapt
immun
like
open
new
avenu
design
better
vaccin
improv
vaccin
strategi
